533P Real-world evidence on safety and effectiveness study of ribociclib plus hormonal therapy in HR+/HER2– advanced breast cancer in the middle east: Interim results from the REALEESA study.
Saved in:
| Title: | 533P Real-world evidence on safety and effectiveness study of ribociclib plus hormonal therapy in HR+/HER2– advanced breast cancer in the middle east: Interim results from the REALEESA study. |
|---|---|
| Authors: | Abdel-Razeq, H.1 (AUTHOR), Alsayed, A.2 (AUTHOR), Dawoud, E.3 (AUTHOR), Al Kharusi, S.S.4 (AUTHOR), Hammad Tirmazy, S.5 (AUTHOR), Ahmed, E.6 (AUTHOR), Alhawari, L.7 (AUTHOR), Kasseb, M.8 (AUTHOR), Soliman, W.9 (AUTHOR) |
| Source: | Annals of Oncology. 2025 Supplement 2, Vol. 36, pS426-S426. 1p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 189418794 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 533P Real-world evidence on safety and effectiveness study of ribociclib plus hormonal therapy in HR+/HER2– advanced breast cancer in the middle east: Interim results from the REALEESA study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Abdel-Razeq%2C+H%2E%22">Abdel-Razeq, H.</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Alsayed%2C+A%2E%22">Alsayed, A.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Dawoud%2C+E%2E%22">Dawoud, E.</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Al+Kharusi%2C+S%2ES%2E%22">Al Kharusi, S.S.</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hammad+Tirmazy%2C+S%2E%22">Hammad Tirmazy, S.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ahmed%2C+E%2E%22">Ahmed, E.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Alhawari%2C+L%2E%22">Alhawari, L.</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kasseb%2C+M%2E%22">Kasseb, M.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Soliman%2C+W%2E%22">Soliman, W.</searchLink><relatesTo>9</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2025 Supplement 2, Vol. 36, pS426-S426. 1p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=189418794 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.annonc.2025.08.956 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: S426 Titles: – TitleFull: 533P Real-world evidence on safety and effectiveness study of ribociclib plus hormonal therapy in HR+/HER2– advanced breast cancer in the middle east: Interim results from the REALEESA study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Abdel-Razeq, H. – PersonEntity: Name: NameFull: Alsayed, A. – PersonEntity: Name: NameFull: Dawoud, E. – PersonEntity: Name: NameFull: Al Kharusi, S.S. – PersonEntity: Name: NameFull: Hammad Tirmazy, S. – PersonEntity: Name: NameFull: Ahmed, E. – PersonEntity: Name: NameFull: Alhawari, L. – PersonEntity: Name: NameFull: Kasseb, M. – PersonEntity: Name: NameFull: Soliman, W. IsPartOfRelationships: – BibEntity: Dates: – D: 02 M: 09 Text: 2025 Supplement 2 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 36 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |
